Avricore Health (AVCRF) Return on Equity (2020 - 2025)

Avricore Health has disclosed Return on Equity across 8 years of filings, most recently posting 0.0% for Q3 2025.

• In Q3 2025, Return on Equity fell 1.0% year-over-year to 0.0%; the TTM figure through Sep 2025 stood at 0.0% (down 1.0% YoY), while the FY2024 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Equity fell to 0.0% in Q3 2025, from 0.0% in the prior quarter.
• Over the last five years, Return on Equity for AVCRF reached as high as 0.01% in Q3 2023 and fell as low as 0.0% in Q3 2025.
• The 4-year median for Return on Equity is 0.01% (2024), against an average of 0.01%.
• The widest YoY moves for Return on Equity: up 0 bps in 2023, down 1 bps in 2023.
• A 4-year view of Return on Equity shows it stood at 0.0% in 2022, then surged by 48 bps to 0.01% in 2023, then decreased by 7 bps to 0.01% in 2024, then sank by 72 bps to 0.0% in 2025.
• According to Business Quant data, Return on Equity over the past three periods registered 0.0%, 0.0%, and 0.01% for Q3 2025, Q2 2025, and Q1 2025 respectively.